Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
17
×
boston blog main
national blog main
boston top stories
life sciences
biotech
clinical trials
startups
deals
national top stories
new york blog main
drugs
new york top stories
fda
investing
venture capital
financing
medical device
cancer
funding
healthcare
machine learning
perceptive advisors
san francisco blog main
san francisco top stories
sanofi
series a
software
tech
third rock ventures
.406 ventures
20/20 healthcare partners
480 biomedical
5g
6 river systems
abbott laboratories
abbvie
accelerated approval
access biotechnology
access industries
What
new
17
×
medicines
medicine
drug
therapeutics
based
biotech
company
drugs
ipo
million
raised
address
aims
approach
bio
body
boston
called
cells
companies
data
develop
developing
device
disease
diseases
fda
genetic
lead
medical
molecules
multiple
neuro
potentially
public
raises
research
rna
second
Language
unset
Current search:
new
×
boston
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@techcrunch.com
4 years ago
Obvious Ventures makes CBD sporty with beam, which sells cannabis products to the GNC set
@xconomy.com
5 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines